Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

E-book reader devices these days come in various shapes and sizes. There are what can be termed the conventional e-reader devices of the sort of the Kindle Paperwhite or the Kobo Clara.

The companies’ main CGM offerings, the Libre and the Dexcom G series, are primarily for people who use insulin, but there are only so many of us to go around. Abbott and Dexcom believe that the Lingo ...

The Meebook M8 is a brand-new e-book reader and is the spiritual successor of the Meebook P78 Pro. This device is primarily marketed as a manga reader and does some light note-taking. The major ...

The final round of voting has closed, and it's time to reveal the winner of our annual Reader's Choice Awards! Beginning in December, DPReview readers picked their favorite cameras, zoom lenses and ...